The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 415.00
Bid: 410.00
Ask: 420.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.439%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 415.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Peter Brotherhood Limited

12 Mar 2021 07:00

RNS Number : 0261S
Avingtrans PLC
12 March 2021
 

12 March 2021

Avingtrans plc

("Avingtrans" or the "Company")

Disposal of Peter Brotherhood Limited

Avingtrans plc, which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce that it has completed the sale of Peter Brotherhood Limited ("Peter Brotherhood") to Howden, a leading global provider of mission critical air and gas handling products, for a total consideration (enterprise value) of £35.0 million (the "Disposal"), which, after adjustment for debt and working capital, will result in the Company receiving net proceeds of approximately £30.6 million, before transaction costs.

Background to the Sale

 

Peter Brotherhood, based in Peterborough, UK, which sat within Avingtrans' Process Solutions and Rotating Equipment ("PSRE") division, specialises in the design, manufacture and servicing of performance-critical steam turbines, turbo gen-sets, compressors, gear boxes and combined heat and power systems. It was acquired in September 2017, as part of the acquisition of the Hayward Tyler Group ("HTG") which attracted total consideration of £52.7m, of which Peter Brotherhood represented approximately £9.3m. Therefore, the Disposal represents a gross return on the original capital investment of almost four times.

 

The Disposal has been orchestrated in-line with the Company's long term Pinpoint-Invest-Exit ("PIE") strategy, which aims to realise value for shareholders. Peter Brotherhood was in difficulty when it was acquired by Avingtrans and a rapid restructuring programme was implemented, followed by a strategy reset. This led to a project to recruit and train an improved sales force, multiple sales agents and a strengthening of the aftermarket team, which proved to be the key to recovery and increased value.

 

To make the next step change in performance at Peter Brotherhood, Avingtrans would have had to enter a multi-year programme of investment. Therefore, the Board decided that the time was right to execute an exit plan, to optimise value for shareholders and to unite the team at Peter Brotherhood with Howden, a global leader in air and gas handling products, which can take the business to the next level.

Peter Brotherhood's revenues for the year ended 31 May 2020 were £25.7 million, resulting in a contribution to Group operating profits of £3.3 million. At the date of sale, the unaudited pro-forma net assets being disposed of, after adjusting for intercompany funding, are approximately £5.0m.

Terms of the Sale

 

The Disposal is for an enterprise value of £35.0 million which, after adjustment for debt and working capital, will result in the Company receiving net proceeds of approximately £30.6 million, before costs. There are no earn out arrangements, or deferred consideration.

 

The sale and purchase agreement contains warranties and indemnities by the Company usual for a transaction of this nature and a covenant by the Company not to compete in the steam turbine and associated market sectors for a limited period of time.

 

Future of the Group Post Sale

 

Following the Disposal, the Group will retain its three core divisions being:

· Energy - Engineered Pumps and Motors

· Energy - Process Solutions and Rotating Equipment

· Medical and Industrial Imaging

 

The impact of the Disposal will therefore to be to reduce the size of the PSRE division, which generated segmental revenues and operating profits (including Peter Brotherhood) of £52.7 million and £3.9 million respectively in the year to 31 May 2020.

 

Use of Sale Proceeds

 

The Board will consider the application of the proceeds from the Disposal following Completion, but it is anticipated that they will be used as follows:

 

· To retain a portion of the proceeds to invest in the current divisions, including to fund the recently announced £3.2m investment in Magnetica - to focus on becoming a market leader in the production of compact, superconducting, helium-free MRI systems, targeted at specific applications - including orthopaedic imaging and veterinary imaging;

· To partially repay the Group's existing debt, whilst retaining appropriate banking facilities and relationships for the future effective operation of the Group; and

· To continue to review potential opportunities, which enhance the Board's Pinpoint-Invest-Exit (PIE) strategic model.

 

The PSRE division will now concentrate on the recovery of Booth Industries and on further business growth opportunities in the nuclear sector - especially at Metalcraft and at the Fluid Handling business in Scotland.

 

Commenting on the announcement, Steve McQuillan, Chief Executive Officer of Avingtrans said:

 

"This well executed exit of Peter Brotherhood once again demonstrates the success of the Avingtrans PIE strategy. Peter Brotherhood was in poor shape when we acquired it in 2017, but it has been turned around to make it attractive to specialist Groups in its sectors. The result is enhanced value for Avingtrans shareholders and the potential opportunity to repeat the PIE model elsewhere.

 

"We are also delighted that the sale unites the Peter Brotherhood team with Howden, another great British engineering company. We wish the new team every success in their future together.

 

"We constantly strive to grow and develop our business portfolio and we are always keen to take advantage of potential exits and new prospects to add further value."

 

Enquiries:

 

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer

N+1 Singer (Nominated Adviser)

02074 963000

Shaun Dobson/Alex Bond (Corporate Finance) Rachel Hayes (Corporate Broking)

SEC Newgate (Financial PR)

02076 539850

Adam Lloyd/ Tom Carnegie

 

 

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.

 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Lapeer, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

  

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has remained at the forefront of MRI systems technology, successfully designing and commercialising a 1.5 Tesla extremity MRI superconducting magnet that is now the heart of over two hundred MRI systems world-wide. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going.

 

 

 

 

About Howden:

Howden is a leading global provider of mission critical air and gas handling products. Howden enables our customers' vital processes which advance a more sustainable world. Based in Glasgow, Scotland, Howden has over 160 years heritage as a world-class application engineering and manufacturing company with a presence in 34 countries. Howden manufactures highly engineered fans, compressors, heat exchangers, steam turbines, and other air and gas handling equipment, and provides service and support to customers around the world in highly diversified end-markets and geographies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUAOWRAVUOAAR
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.